Researchers use a novel genomic approach to better understand genetic mutations associated with familial Alzheimer’s disease.
A new study provides insight into the link between ApoE4 and SirT1, an anti-aging protein found is resveratrol.
Researchers have identified and validated two rare gene mutations which could be a cause for late onset Alzheimer’s disease.
Researchers reveal how two classes of drug compounds, which are currently in trial, work to fight Alzheimer’s disease. They also identify possible causes of early onset hereditary forms of AD.
Researchers have identified key molecular pathways which lead to late-onset Alzheimer’s disease. The study presents a new approach to Alzheimer’s research and highlights several potential drug targets.
An international research team revealed the atomic‐level structure of the human peptidase enzyme meprin β (beta).
Gene involved in dementia affects the insulin pathway, reports biology professor Chris Li and colleagues. In recent years it became clear that people with diabetes face an ominous prospect – a far greater risk of developing Alzheimer’s disease. Now researchers at The City College of New York (CCNY) have shed light on one reason why. […]
A study led by Karolinska Institutet reports for the first time the positive effects of an active vaccine against Alzheimer’s disease. The new vaccine, CAD106, can prove a breakthrough in the search for a cure for this seriously debilitating dementia disease. The study is published in the distinguished scientific journal Lancet Neurology. Alzheimer’s disease is […]